Screener
Jade Biosciences JBIO Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development(1) | $36,053 | $20,023 |
| General and administrative(2) | 7,392 | 3,361 |
| Total operating expenses | 43,445 | 23,384 |
| Loss from operations | (43,445) | (23,384) |
| Other income (expense): | ||
| Interest income | 3,102 | 615 |
| Change in fair value of Convertible Notes payable(3) | — | (15,400) |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's total operating expenses?
- Jade Biosciences (JBIO) reported total operating expenses of $43.45M in Q1 2026.
- How has Jade Biosciences's total operating expenses changed year-over-year?
- Jade Biosciences's total operating expenses increased by 85.8% year-over-year, from $23.38M to $43.45M.
- What is the long-term trend for Jade Biosciences's total operating expenses?
- Over 4 years (2021 to 2025), Jade Biosciences's total operating expenses has grown at a 49.0% compound annual growth rate (CAGR), from $23.02M to $113.54M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Jade Biosciences's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude